Leukemia, B-Cell: Clinical Trials

2 trials for Leukemia, B-Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Suspended 2

Follow Leukemia, B-Cell: new trials by email Literature Review of Leukemia, B-Cell trials Research Report on Leukemia, B-Cell

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Vactosertib, Fludarabine Phosphate, Cyclophosphamide - Colorectal Cancer, Hematologic Malignancy
Phase 1SuspendedDavid Wald122022-09-092026-07-14
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
P1446A-05 - Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Phase 1SuspendedPiramal Enterprises Limited362014-06-012014-09-03

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm Metastasis (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Rectal Neoplasms (1)  ·  Stomach Neoplasms (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Cyclophosphamide (1)  ·  IL32 protein, human (1)  ·  Interleukin-2 (1)  ·  aldesleukin (1)  ·  fludarabine phosphate (1)  ·  vactosertib (1)

Sponsors

David Wald (1)  ·  Piramal Enterprises Limited (1)

Countries

United States (2)

Top investigators

Benjamin Tomlinson, MD (1)  ·  Dr Alexey V Danilov, MD, PhD (1)  ·  Dr Jennifer R Brown, MD, PhD (1)